- Product Details
Keywords
- Tenofovir alafenamide fumarate
- Tenofovir Alafenamide Hemifumarate
- TENOFOVIR INTERMEDIATES
Quick Details
- ProName: Tenofovir alafenamide fumarate / Tenof...
- CasNo: 1392275-56-7
- Molecular Formula: C21H29N6O5P.C4H4O4
- Appearance: white powder
- Application: reduce the amount of HIV in the body
- DeliveryTime: immediately after payment receives
- PackAge: discreet packing
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 500 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 10 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
Name: Tenofovir alafenamide
Synonyms: GS-7340 (fuMarate)
CAS NO.: 379270-38-9
Strucrure: Supply Tenofovir alafenamide CAS NO.:379270-38-9
Application: Pharmaceutical Intermediates
Purity: 99%
Appearance : powder
Tenofovir alafenamide, also known as TAF and GS-7340, is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevent HIV from multiplying and can reduce the amount of HIV in the body. Tenofovir alafenamide is a prodrug, which means that it is an inactive drug. In the body, tenofovir alafenamide is converted to tenofovir diphosphate (TFV-DP). Tenofovir alafenamide fumarate was approved in November 2015 for treatment of HIV-1.
Packing and shipping